Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Neumora Therapeutics, Inc. | 309,092 | reported | 18 Feb 2025 | tx 14+1,608,809−696,783 |
| LB PHARMACEUTICALS INC | 20,000 | reported | 06 Mar 2026 | tx 1+20,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Mar 2026 | GRANT_AWARD | LB PHARMACEUTICALS INC | 20,000 | 0.00 USD | deriv |
| 18 Feb 2025 | SALE | Neumora Therapeutics, Inc. | 5,614 | 1.67 USD | |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 502,934 | — | deriv |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 100,000 | — | deriv |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 502,934 | — | deriv |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 100,000 | — | deriv |
| 09 Oct 2024 | SALE | Neumora Therapeutics, Inc. | 5,563 | 15.01 USD | |
| 10 Oct 2024 | SALE | Neumora Therapeutics, Inc. | 8,260 | 15.09 USD | |
| 18 Sept 2024 | SALE | Neumora Therapeutics, Inc. | 10,676 | 12.09 USD | |
| 17 Sept 2024 | SALE | Neumora Therapeutics, Inc. | 30,788 | 11.81 USD | |
| 12 Sept 2024 | SALE | Neumora Therapeutics, Inc. | 32,948 | 11.43 USD | |
| 14 Feb 2024 | GRANT_AWARD | Neumora Therapeutics, Inc. | 50,000 | 0.00 USD | |
| 14 Feb 2024 | GRANT_AWARD | Neumora Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 14 Sept 2023 | GRANT_AWARD | Neumora Therapeutics, Inc. | 352,941 | 0.00 USD | |
| 14 Sept 2023 | GRANT_AWARD | Neumora Therapeutics, Inc. | 502,934 | 0.00 USD | deriv |